Bioceres Crop Solutions (BIOX) 2019年年度报告「NASDAQ」.pdf

1、TableofContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 20-F(Mark One)ooREGISTRATION STATEMENT PURSUANT TO SECTION 12(b)OR (g)OF THE SECURITIES EXCHANGEACT OF 1934 OR xx ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal

2、year ended June 30,2019 OR ooTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934 For the transition period from to OR ooSHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACTOF 1934Dateofeventrequiringthisshellcompanyreport:Commissionfil

3、enumber:001-38836Bioceres Crop Solutions Corp.(ExactnameofRegistrantasspecifiedinitscharter)Cayman Islands(Jurisdictionofincorporation)Ocampo 210 bis,Predio CCT,RosarioProvince of Santa Fe,Argentina(Addressofprincipalexecutiveoffices)Gloria MontaronExecutive DirectorOcampo 210 bis,Predio CCT,Rosario

4、Province of Santa Fe,ArgentinaPhone:54-341-4861122Email:(Name,Telephone,E-mailand/orFacsimilenumberandAddressofCompanyContactPerson)Copiesto:Conrado Tenaglia,Esq.Matthew S.Poulter,Esq.Linklaters LLP1345 Avenue of the AmericasNew York,NY 10105Phone:(212)903-9000Fax:(212)903-9100Securitiesregisteredor

5、toberegisteredpursuanttoSection12(b)oftheAct:Title of each classTrading SymbolName of each exchange on which registeredOrdinaryShares,parvalueUS$0.0001pershareBIOXNYSEAmericanLLCWarrants,exercisableforordinarysharesBIOX.WASNYSEAmericanLLCTableofContentsSecuritiesregisteredortoberegisteredpursuanttoS

6、ection12(g)oftheAct:NoneSecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct:Ordinary SharesWarrantsIndicatethenumberofoutstandingsharesofeachoftheissuersclassesofcapitalstockorcommonstockasofthecloseofbusinesscoveredbytheannualreport.36,120,517ordinaryshareswereissuedandoutst